Clinicopathologic characteristics of prefibrotic-early primary myelofibrosis in Chinese patients

Human Pathology

Volumn 45, Issue 3, 2014, Pages 498-503

  Gong, Xubo ^a   Lu, Xingguo ^a   Xiao, Xibin ^a   Wang, Weiqin ^a   Yang, Jin ^a   Fu, Yanbiao ^a   Zheng, Yanbo ^b   Tang, Qiusu ^a   Zhang, Xiaohong ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Essential thrombocythemia; Megakaryocytes; Prefibrotic early primary myelofibrosis

Indexed keywords

ESSENTIAL THROMBOCYTHEMIA; MEGAKARYOCYTES; PREFIBROTIC-EARLY PRIMARY MYELOFIBROSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BONE MARROW; CHINA; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; JANUS KINASE 2; MALE; MEGAKARYOCYTES; MIDDLE AGED; MUTATION; PRIMARY MYELOFIBROSIS; SEX FACTORS; TIME FACTORS;

EID: 84894096063     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.08.021     Document Type: Article

References (23)

1. R.A. Van Etten, S. Koschmieder, and F. Delhommeau et al. The Ph-positive and Ph-negative myeloproliferative neoplasms: some topical pre-clinical and clinical issues Haematologica 96 2011 590 601
2. S.H. Swerdlow, E. Campo, and N.L. Harris et al. Pathology and genetics of tumors of haematopoietic and lymphoid tissues 4th ed World Health Organization classification of tumors 2008 IARC Press Lyon
3. A. Tefferi, J. Thiele, and A. Orazi et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel Blood 110 2007 1092 1097
4. S. Murphy, P. Peterson, H. Iland, and J. Laszlo Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment Semin Hematol 34 1997 29 39
5. T.C. Pearson, and M. Messinezy The diagnostic criteria of polycythaemia rubra vera Leuk Lymphoma 22 1996 87 93
6. E.S. Jaffe, N.L. Harris, H. Stein, and J.W. Vardiman Pathology and genetics of tumours of haematopoietic and lymphoid tissues World Health Organization Classification of Tumours 2001 IARC Press Lyon
7. J. Thiele, H.M. Kvasnicka, R. Zankovich, and V. Diehl Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis Haematologica 85 2000 1126 1134
8. J. Thiele, and H.M. Kvasnicka Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients Ann Hematol 82 2003 148 152
9. J. Thiele, H.M. Kvasnicka, and A. Schmitt-Graeff et al. Follow-up examinations including sequential bone marrow biopsies in essential thrombocythemia (ET): a retrospective clinicopathological study of 120 patients Am J Hematol 70 2002 283 291
10. J. Thiele, H.M. Kvasnicka, and R. Zankovich et al. Early-stage idiopathic (primary) myelofibrosis: current issues of diagnostic features Leuk Lymphoma 43 2002 1035 1041
11. T. Barbui, J. Thiele, and F. Passamonti et al. Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study J Clin Oncol 29 2011 3179 3184
12. B.S. Wilkins, W.N. Erber, and D. Bareford et al. Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes Blood 111 2008 60 70
13. A.M. Florena, C. Tripodo, and E. Iannitto et al. Value of bone marrow biopsy in the diagnosis of essential thrombocythemia Haematologica 89 2004 911 919
14. G. Xubo, L. Xingguo, and W. Xianguo et al. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia Eur J Haematol 83 2009 292 301
15. H. Quentmeier, R.A. MacLeod, M. Zaborski, and H.G. Drexler JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders Leukemia 20 2006 471 476
16. M.N. Lauw, E.W. Bus, and A.F. Van Wulfften Palthe et al. Relevance of the JAK2 V617F mutation in patients with deep vein thrombosis of the leg Ann Hematol 91 2012 103 107
17. J. Thiele, H.M. Kvasnicka, and L. Müllauer et al. Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification Blood 117 2011 5710 5718
18. M. Brousseau, E. Parot-Schinkel, and M.P. Moles et al. Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis Histopathology 56 2010 758 767
19. G. Barosi, V. Rosti, and E. Bonetti et al. Evidence that prefibrotic myelofibrosis is aligned along a clinical and biological continuum featuring primary myelofibrosis PLoS One 7 2012 e35631
20. J. Thiele, and H.M. Kvasnicka Diagnostic differentiation of essential thrombocythaemia from thrombocythaemias associated with chronic idiopathic myelofibrosis by discriminate analysis of bone marrow features: a clinicopathological study on 272 patients Histol Histopathol 18 2003 93 102
21. R.P. Gale, W. Cozen, and M.T. Goodman et al. Decreased chronic lymphocytic leukemia incidence in Asians in Los Angeles County Leuk Res 24 2000 665 669
22. L. Li, X.P. Liu, L. Nie, and M.H. Yu et al. Unique cytogenetic features of primary myelodysplastic syndromes in Chinese patients Leuk Res 33 2009 1194 1198
23. A. Matsuda, U. Germing, and I. Jinnai et al. Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes Blood 106 2005 2633 2640